한글목차

HIV/에이즈 진단 시장 규모는 2025년 57억 8,000만 달러에서 2034년에는 141억 2,000만 달러에 이르고, 2026-2034년 CAGR 10.44%를 나타낼 전망입니다.

세계 HIV/에이즈 진단 시장은 인식 제고, 조기 발견 프로그램 및 세계 보건 이니셔티브에 힘입어 꾸준히 성장하고 있습니다. HIV 진단은 조기 진단과 적절한 치료를 가능하게 함으로써 감염 확산을 억제하는 데 중요한 역할을 하고 있습니다. 각국 정부 및 국제기구는 검사 서비스 접근성을 개선하기 위해 선별검사 캠페인과 검사실 인프라에 많은 투자를 하고 있습니다.

주요 성장 요인으로는 검사 프로그램 증가, 신속 진단 키트의 보급, 검사 기술의 발전 등을 꼽을 수 있습니다. 특히 개발도상국에서는 현장 검사 및 자가 검사 키트의 도입으로 검사 접근성이 크게 향상되었습니다. 또한, 보다 정확하고 신속한 진단 도구의 개발이 진행됨에 따라 감지율이 향상되고 환자 관리 전략이 개선되고 있습니다.

향후 몇 년 동안 공중보건 위협인 HIV/에이즈 퇴치를 위한 전 세계적인 노력이 지속됨에 따라 시장은 성장할 것으로 예측됩니다. 분자진단 기술과 디지털 헬스 통합의 발전으로 효율성과 모니터링이 향상될 것입니다. 아프리카와 아시아태평양에서는 높은 검사 수요로 인해 높은 성장이 예상되는 반면, 선진 지역에서는 고도의 자동화된 진단 시스템에 초점을 맞출 것으로 예측됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 HIV/에이즈 진단 시장 : 제품 유형별

제5장 세계의 HIV/에이즈 진단 시장 : 테스트 유형별

제6장 세계의 HIV/에이즈 진단 시장 : 최종사용자별

제7장 세계의 HIV/에이즈 진단 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The HIV/AIDS Diagnostics Market size is expected to reach USD 14.12 Billion in 2034 from USD 5.78 Billion (2025) growing at a CAGR of 10.44% during 2026-2034.

The Global HIV/AIDS Diagnostics market is expanding steadily due to increased awareness, early detection programs, and global health initiatives. HIV diagnostics play a crucial role in controlling the spread of infection by enabling early diagnosis and timely treatment. Governments and international organizations are investing heavily in screening campaigns and laboratory infrastructure to improve access to testing services.

Major growth drivers include the rising number of testing programs, availability of rapid diagnostic kits, and improvements in laboratory technologies. Point-of-care testing and self-testing kits have significantly increased accessibility, especially in developing regions. In addition, ongoing research for more accurate and faster diagnostic tools is enhancing detection rates and supporting better patient management strategies.

In the coming years, the market is expected to grow with continuous global efforts to eliminate HIV/AIDS as a public health threat. Technological advancements in molecular diagnostics and digital health integration will improve efficiency and monitoring. Africa and Asia-Pacific are expected to witness strong growth due to high testing demand, while developed regions focus on advanced and automated diagnostic systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Kits And Reagents
• Others

By Test Type

• Nucleic Acid Tests
• Rapid Tests (POC)
• ELISA
• Others

By End-user

• Private Diagnostics Laboratories
• Hospitals
• Research Institutes & Others
• Academic

COMPANIES PROFILED

• Hologic Inc, Alere, BioRad Laboratories, Abbott Laboratories, F HoffmannLa Roche Ltd, OraSure Technologies Inc, Siemens Healthineers, Chembio Diagnostic Systems
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Kits And Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Nucleic Acid Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rapid Tests (POC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Private Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Research Institutes & Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIV/AIDS DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Hologic Inc
  • 9.2.2 Alere
  • 9.2.3 Bio-Rad Laboratories
  • 9.2.4 Abbott Laboratories
  • 9.2.5 F. Hoffmann-La Roche Ltd
  • 9.2.6 OraSure Technologies Inc
  • 9.2.7 Siemens Healthineers
  • 9.2.8 Chembio Diagnostic Systems